{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T18:51:09Z","timestamp":1784400669020,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T00:00:00Z","timestamp":1222214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10048-008-0150-4","type":"journal-article","created":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T08:35:01Z","timestamp":1222158901000},"page":"13-17","source":"Crossref","is-referenced-by-count":68,"title":["Alzheimer\u2019s disease risk variants show association with cerebrospinal fluid amyloid beta"],"prefix":"10.1007","volume":"10","author":[{"given":"John S. K.","family":"Kauwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Goate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,24]]},"reference":[{"key":"150_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer\u2019s disease. Ann Neurol 45:358\u2013368. doi: 10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","journal-title":"Ann Neurol"},{"key":"150_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/archneur.58.3.39711","volume":"58","author":"JC Morris","year":"2001","unstructured":"Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH et al (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58:397\u2013405. doi: 10.1001\/archneur.58.3.39711","journal-title":"Arch Neurol"},{"key":"150_CR3","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/00005072-199812000-00009","volume":"57","author":"CM Hulette","year":"1998","unstructured":"Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM (1998) Neuropathological and neuropsychological changes in \u201cnormal\u201d aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57:1168\u20131174. doi: 10.1097\/00005072-199812000-00009","journal-title":"J Neuropathol Exp Neurol"},{"key":"150_CR4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC et al (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837\u20131844. doi: 10.1212\/01.wnl.0000219668.47116.e6","journal-title":"Neurology"},{"key":"150_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ana.21099","volume":"61","author":"JS Kauwe","year":"2007","unstructured":"Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM et al (2007) Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer\u2019s disease presenilin 1 mutation. Ann Neurol 61:446\u2013453. doi: 10.1002\/ana.21099","journal-title":"Ann Neurol"},{"key":"150_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR et al (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59:512\u2013519. doi: 10.1002\/ana.20730","journal-title":"Ann Neurol"},{"key":"150_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM (2007) Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64:343\u2013349. doi: 10.1001\/archneur.64.3.noc60123","journal-title":"Arch Neurol"},{"key":"150_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17\u201323. doi: 10.1038\/ng1934","journal-title":"Nat Genet"},{"key":"150_CR9","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1073\/pnas.0630494100","volume":"100","author":"C Ding","year":"2003","unstructured":"Ding C, Cantor CR (2003) A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS. Proc Natl Acad Sci U S A 100:3059\u20133064. doi: 10.1073\/pnas.0630494100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"150_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","volume":"47","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM et al (2000) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer\u2019s disease model. Ann Neurol 47:739\u2013747. doi: 10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","journal-title":"Ann Neurol"},{"key":"150_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C et al (2007) Abeta40 inhibits amyloid deposition in vivo. J Neurosci 27:627\u2013633. doi: 10.1523\/JNEUROSCI.4849-06.2007","journal-title":"J Neurosci"},{"key":"150_CR12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 2:864\u2013870. doi: 10.1038\/nm0896-864","journal-title":"Nat Med"},{"key":"150_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/gepi.10252","volume":"25","author":"F Dudbridge","year":"2003","unstructured":"Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115\u2013121. doi: 10.1002\/gepi.10252","journal-title":"Genet Epidemiol"},{"key":"150_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1471-4159.2005.03548.x","volume":"96","author":"J Wang","year":"2006","unstructured":"Wang J, Beher D, Nyborg AC, Shearman MS, Golde TE, Goate A (2006) C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation. J Neurochem 96:218\u2013227","journal-title":"J Neurochem"},{"key":"150_CR15","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/hmg\/7.11.1745","volume":"7","author":"B Keavney","year":"1998","unstructured":"Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E et al (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745\u20131751. doi: 10.1093\/hmg\/7.11.1745","journal-title":"Hum Mol Genet"},{"key":"150_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/hmg\/ddg094","volume":"12","author":"PG Kehoe","year":"2003","unstructured":"Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B et al (2003) Haplotypes extending across ACE are associated with Alzheimer\u2019s disease. Hum Mol Genet 12:859\u2013867. doi: 10.1093\/hmg\/ddg094","journal-title":"Hum Mol Genet"},{"key":"150_CR17","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1212\/01.WNL.0000128088.08695.05","volume":"62","author":"JA Prince","year":"2004","unstructured":"Prince JA, Zetterberg H, Andreasen N, Marcusson J, Blennow K (2004) APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 62:2116\u20132118","journal-title":"Neurology"},{"key":"150_CR18","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1093\/hmg\/ddm171","volume":"16","author":"O Belbin","year":"2007","unstructured":"Belbin O, Dunn JL, Ling Y, Morgan L, Chappell S, Beaumont H et al (2007) Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer\u2019s disease. Hum Mol Genet 16:2199\u20132208. doi: 10.1093\/hmg\/ddm171","journal-title":"Hum Mol Genet"},{"key":"150_CR19","doi-asserted-by":"crossref","first-page":"47863","DOI":"10.1074\/jbc.M104068200","volume":"276","author":"J Hu","year":"2001","unstructured":"Hu J, Igarashi A, Kamata M, Nakagawa H (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276:47863\u201347868","journal-title":"J Biol Chem"},{"key":"150_CR20","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1093\/hmg\/ddl178","volume":"15","author":"Y Li","year":"2006","unstructured":"Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JS, Smemo S et al (2006) DAPK1 variants are associated with Alzheimer\u2019s disease and allele-specific expression. Hum Mol Genet 15:2560\u20132568. doi: 10.1093\/hmg\/ddl178","journal-title":"Hum Mol Genet"},{"key":"150_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1385\/JMN:24:1:129","volume":"24","author":"LJ Morse","year":"2004","unstructured":"Morse LJ, Payton SM, Cuny GD, Rogers JT (2004) FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein. J Mol Neurosci 24:129\u2013136. doi: 10.1385\/JMN:24:1:129","journal-title":"J Mol Neurosci"},{"key":"150_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1471-4159.2006.03770.x","volume":"97","author":"L Reznichenko","year":"2006","unstructured":"Reznichenko L, Amit T, Zheng H, Avramovich-Tirosh Y, Youdim MB, Weinreb O et al (2006) Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (\u2212)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer\u2019s disease. J Neurochem 97:527\u2013536. doi: 10.1111\/j.1471-4159.2006.03770.x","journal-title":"J Neurochem"},{"key":"150_CR23","doi-asserted-by":"publisher","unstructured":"Schjeide B-MM, McQueen MB, Mullin K, DiVito J, Hogan MF, Parkinson M, Hooli B, Lange C, Blacker D, Tanzi RE, Bertram L (2009) Assessment of Alzheimer\u2019s disease case\u2013control associations using family-based methods. Neurogenetics. doi: 10.1007\/s10048-008-0151-3","DOI":"10.1007\/s10048-008-0151-3"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-008-0150-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10048-008-0150-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-008-0150-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:02:33Z","timestamp":1559116953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10048-008-0150-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["150"],"URL":"https:\/\/doi.org\/10.1007\/s10048-008-0150-4","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,24]]}}}